Conference Agenda 2024

  • 08:00
  • Registration & Refreshments

    Kick off your conference experience by checking in at our registration desk. Collect your event materials and enjoy a selection of refreshments. It's the perfect time to mingle with fellow attendees and set the tone for an engaging and informative event

  • 08:50
  • Welcome Address & Chairperson’s opening remarks

    Begin your conference journey with a warm welcome from our esteemed Chairperson


    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

Enhancing Efficiency through Streamlined Clinical Trials

  • 09:00
  • Tactical and Strategic Use of AI in Clinical Trials

    The integration of AI in the planning and conduct of clinical trials is gaining significant attention in the biopharmaceutical industry. This keynote presentation will provide a comprehensive exploration of tactical and strategic applications of AI in the design, execution, and analysis and reporting of clinical trials and across the clinical development lifecycle. Moreover, it will highlight the impact of AI on the roles within clinical development, providing insights into the evolving landscape of the industry. This presentation will offer a compelling and thought-provoking perspective of the transformative potential of AI in clinical development.


    Richardus Vonk

    Richardus Vonk VP, Head of Oncology Data Analytics and Statistical Sciences
    Bayer AG

  • 09:30
  • Integrating Blockchain into clinical research


    Jose Manuel Cervera Grau

    Jose Manuel Cervera Grau Executive Director
    Eli Lilly and Company

  • 10:00
  • Innovating with AI: digital transformations for clinical research

    Clinical trials are one of the most expensive parts of the drug development process; thus one of the goals of clinical trial professionals is to increase efficiency along the process. There is a huge amount of excitement around new innovations in AI technology, but it's not always easy to cut through the noise and find out where these innovations can really bring value to clinical research. In this talk, we will provide an overview of some of the latest innovations in AI & NLP (natural language processing), for translation, privacy, and insights, and showcase recent use cases from pharma and healthcare customers.


    Jane Reed

    Jane Reed Director of Life Sciences NLP
    Linguamatics

  • 10:30
  • Ensuring Compliance and Inspection Readiness Through Effective Risk Management


    Miguel Valenzuela

    Miguel Valenzuela Associate Director Clinical Operations - RBQM+
    Alnylam Pharmaceuticals

  • 11:00
  • Business Card Exchange with Morning Coffee/Tea & Discussion

    Network over morning coffee or tea, exchanging business cards or using our app's QR code scanner for easy contact sharing. A prime moment for engaging discussions and new connections

     

         

  • 11:20
  • Forging Successful Global Research Partnership in Southeast Asia - Universiti Malaya Medical Centre's Experience


    Prof. Dr. Ho Gwo Fuang

    Prof. Dr. Ho Gwo Fuang Consultant clinical oncologist
    Clinical Investigation Centre, UMMC

  • 11:50
  • Advancing Patient Safety Through Inclusive Clinical Trials: Harnessing Real-World Data Directly from Source


    Martin Gibson

    Martin Gibson Chief Medical Officer
    NorthWest EHealth

  • 12:20
  • Digital Transformation: Developing and deploying a digital authoring platform across the value chain


    Waheed Jowiya

    Waheed Jowiya Digitalisation Strategy Lead
    Novo Nordisk

    Louise Lind Skov

    Louise Lind Skov Head of Content Digitalisation
    Novo Nordisk

  • 12:45
  • Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths

    Enjoy a luncheon while networking with peers and exploring exhibitor booths. This is an ideal time to engage with industry leaders, delve into innovative solutions, and forge valuable connections in a collaborative atmosphere.

     

                

  • 13:35
  • Increasing diversity in clinical trials in the UK: Results from a nationally representative survey


    Rebecca West

    Rebecca West Associate Director leading Global Health
    Ipsos

  • 14:00
  • Patient Involvement and Patient Reported Outcomes. Does it make a difference?


    Regine Buffels

    Regine Buffels Principal Global Medical Affairs Director
    Hoffmann-La Roche

  • 14:30
  • End-to-End management of critical quality factors across a vaccine study/program


    Magali Traskine

    Magali Traskine Associate Director, Central Monitoring
    GSK

  • 15:00
  • From EHR to Sponsor – harnessing electronic health records in clinical research


    Rebecca Jackson

    Rebecca Jackson Senior Manager, R&D IT, Enabling Innovation
    Johnson & Johnson Technology

  • 15:30
  • Recharge with Tea or Coffee While Networking

    Refresh with a tea or coffee break, using this time to continue networking. It's a perfect opportunity to discuss ideas, share experiences, and connect with fellow attendees in a relaxed setting.

     

         

  • 15:50
  • Panel discussion: Critical Success Factors while Planning for Site Selection and Patient Recruitment

    • Discover sites with a demonstrated track record of good execution in trials
    • Study and site staff with solid certifications to expand the likelihood of powerful enrolment and an effective trial.
    • Factors such as disease prevalence rates, treatment practices, regulatory requirements and statistical considerations must be considered.
    • Access to subject population with the required eligibility criteria
    • Network within industries

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

    Viraj Rajadhyaksha

    Viraj Rajadhyaksha Area Medical Director
    AstraZeneca

    Diane Driver

    Diane Driver Head Program Delivery
    UCB

    Rasmus Hjorth

    Rasmus Hjorth Head of communication
    James Lind Care

  • 16:20
  • The Role of Investigator-Initiated Trials in Leveraging Real-World Evidence


    Viraj Rajadhyaksha

    Viraj Rajadhyaksha Area Medical Director
    AstraZeneca

  • 16:50
  • Sponsor centric to Patient centric framework - Improving patient recruitment & enhancing their involvement


    Lucy Campbell

    Lucy Campbell Research Manager
    King's College London

  • 17:20
  • Panel Discussion: The Future of Patient-Centricity in Clinical Trials - Embedding a patient-centric approach to clinical trial design

    • How to integrate patient feedback into clinical trial design effectively.
    • The role of digital health technologies in enhancing patient engagement and experience.
    • Strategies for maintaining communication and trust with participants throughout the trial.
    • The impact of patient-centric approaches on trial outcomes and drug development timelines.
    • Ethical considerations and data privacy in a patient-centered model.

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

    Sophie Wintrich

    Sophie Wintrich Patient Advocacy Connector
    Patient Co-Next

    Diane Driver

    Diane Driver Head Program Delivery
    UCB

    Lukasz Wiech

    Lukasz Wiech Chief Medical Officer
    European Clinical Trials Information Network

  • 17:50
  • Interactive Breakout Round Table Discussion

    All the participants will have a great opportunity to discuss and explore a selection of most interesting topics discussed during the conference in small groups with their industry colleagues in an informal setting.

    Table 1 - Revolutionizing Patient Recruitment: Strategies for Today’s Digital World 
    Exploring the intersection of digital marketing, social media, and patient advocacy in enhancing recruitment efficiency. 

    Table 2 - Mastering the Art of Site Selection: Balancing Technology, Geography, and Patient Access 
    Delving into the criteria and tools that can optimize site selection for diverse and technologically advanced clinical trials. 

    Table 3 - Harnessing Data Science: The New Frontier in Trial Design and Real-World Evidence 
    Discussing the transformative potential of big data analytics, AI, and real-world evidence in the design and execution of clinical trials. 

    Table 4 - The Evolving Landscape of Clinical Trial Regulations: Global Perspectives and Harmonization 
    Navigating the complexities of international regulatory environments and striving for a harmonized approach to global clinical trials. 

    Table 5- Patient-Centricity in Clinical Trials: More Than Just a Buzzword? 
    Evaluating the real-world application of patient-centric approaches in trial design, conduct, and outcomes.

    Table 6- Innovation in Trial Monitoring and Quality Assurance: Risk-Based Approaches and Beyond 
    Examining the latest methodologies in risk-based monitoring, quality by design, and the role of clinical auditing in ensuring trial integrity.

  • 18:20
  • Chairperson’s Closing Remark

    End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.

  • 18:30
  • Networking Drinks Session - Unwind with Evening Drinks and Engaging Conversations

    Wrap up the day with evening drinks and lively conversations. A relaxed setting to network, share insights from the day, and enjoy the company of fellow attendees.


 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now